Hype around worm study on potential Alzheimer's treatment is derided

A group of scientists from the University of Cambridge, Lund University and the University of Groningen concluded that the lymphoma drug bexarotene may interrupt the first step in the process that leads to Alzheimer's. The conclusion was reached after studying the drug on worm models for the disease. And the resulting headlines in U.K. newspapers about a potential cure for Alzheimer's led to considerable hooting on Twitter, where it was called out as another example of hyping preclinical studies. Release

Suggested Articles

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.

Brigham and Women’s Hospital scientists linked a noncoding RNA to atherosclerosis in a discovery that could aid in the development of new heart drugs.